TVRD

Tvardi Therapeutics

79 hedge funds and large institutions have $4.56M invested in Tvardi Therapeutics in 2024 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 15 increasing their positions, 24 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
79
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$16K
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$204K
2 +$107K
3 +$97.1K
4
Goldman Sachs
Goldman Sachs
New York
+$87.2K
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$52K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$25K
27
$24K
28
$20K
29
$19.3K
30
$18.8K
31
$18K
32
$17.9K
33
$17.2K
34
$15.9K
35
$14.8K
36
$14.2K
37
$11.8K
38
$8.97K
39
$8.52K
40
$7.91K
41
$7.62K
42
$6.3K
43
$5.81K
44
$5.2K
45
$5.13K
46
$4K
47
$3.7K
48
$3.48K
49
$3.39K
50
$3.13K